PGP and neoplasm: Such an approach could pave the way to evaluation of clinical samples, such as patient biopsies, to predict drug response and develop appropriate treatment regimes, but significant validation must be done to determine whether tumor P-gp expression levels can be used as a reliable indicator of chemotherapeutic susceptibility.